{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:45:51Z","timestamp":1792089951874,"version":"4.4.0"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Osteoarthritis is a whole-joint disease in which cartilage loss, synovial inflammation, subchondral bone remodelling and pain-related neural changes co-evolve, yet structural improvement does not reliably translate into pain relief. This Review centres prostaglandin E\n                    <jats:sub>2<\/jats:sub>\n                    (PGE\n                    <jats:sub>2<\/jats:sub>\n                    ) skeletal interoception in the translational framework for 15-hydroxyprostaglandin dehydrogenase (15-PGDH) inhibition. In skeletal interoception, PGE\n                    <jats:sub>2<\/jats:sub>\n                    produced in mechanically stressed bone and osteochondral tissues is sensed by prostaglandin E receptor 4 (EP4)-positive sensory afferents, relayed to central circuits and translated into altered sympathetic norepinephrine output. Because 15-PGDH catabolises PGE\n                    <jats:sub>2<\/jats:sub>\n                    , its inhibition may prolong the persistence and spatial reach of this interoceptive cue while also acting locally on chondrocyte state. This combined local and interoceptive action offers a plausible mechanism for cartilage repair and pain modulation, but may also create compartment-specific risk when prolonged PGE\n                    <jats:sub>2<\/jats:sub>\n                    persists in synovium or subchondral bone. We compare 15-PGDH inhibition with upstream synthesis blockade and receptor-specific strategies, and propose that development should be organised around three checkpoints: cartilage-enriched exposure, durability under mechanical load and structure\u2013pain coherence. Current evidence supports cautious development rather than broad generalisation; clinical translation will require compartment-resolved pharmacokinetics\/pharmacodynamics, EP-receptor attribution and early surveillance for synovial, osteochondral and pain-system liabilities.\n                  <\/jats:p>","DOI":"10.1038\/s41413-026-00589-3","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:02:22Z","timestamp":1792058542000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["15-PGDH inhibition in osteoarthritis: PGE2 skeletal interoception, cartilage regeneration and compartment-managed disease modification"],"prefix":"10.1038","volume":"14","author":[{"given":"Qiaojie","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7136-4528","authenticated-orcid":false,"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,15]]},"reference":[{"key":"589_CR1","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/s41584-025-01332-8","volume":"22","author":"KH Collins","year":"2026","unstructured":"Collins, K. H., Haugen, I. K., Neogi, T. & Guilak, F. Osteoarthritis as a systemic disease. Nat. Rev. Rheumatol. 22, 105\u2013117 (2026).","journal-title":"Nat. Rev. Rheumatol."},{"key":"589_CR2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0140-6736(24)02322-5","volume":"405","author":"M Kloppenburg","year":"2025","unstructured":"Kloppenburg, M., Namane, M. & Cicuttini, F. Osteoarthritis. Lancet 405, 71\u201385 (2025).","journal-title":"Lancet"},{"key":"589_CR3","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/s41584-023-00979-5","volume":"19","author":"S Muthu","year":"2023","unstructured":"Muthu, S. et al. Failure of cartilage regeneration: emerging hypotheses and related therapeutic strategies. Nat. Rev. Rheumatol. 19, 403\u2013416 (2023).","journal-title":"Nat. Rev. Rheumatol."},{"key":"589_CR4","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41584-025-01280-3","volume":"21","author":"V Batchelor","year":"2025","unstructured":"Batchelor, V., Perry, T. A., Cader, M. Z. & Vincent, T. L. Peripheral neuronal sensitization and neurovascular remodelling in osteoarthritis pain. Nat. Rev. Rheumatol. 21, 526\u2013545 (2025).","journal-title":"Nat. Rev. Rheumatol."},{"key":"589_CR5","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s41584-025-01271-4","volume":"21","author":"H Peters","year":"2025","unstructured":"Peters, H., Rockel, J. S., Little, C. B. & Kapoor, M. Synovial fluid as a complex molecular pool contributing to knee osteoarthritis. Nat. Rev. Rheumatol. 21, 447\u2013464 (2025).","journal-title":"Nat. Rev. Rheumatol."},{"key":"589_CR6","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41584-025-01234-9","volume":"21","author":"J Barroso","year":"2025","unstructured":"Barroso, J., Branco, P. & Apkarian, A. V. The causal role of brain circuits in osteoarthritis pain. Nat. Rev. Rheumatol. 21, 261\u2013274 (2025).","journal-title":"Nat. Rev. Rheumatol."},{"key":"589_CR7","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41584-023-01021-4","volume":"19","author":"T Neogi","year":"2023","unstructured":"Neogi, T. & Colloca, L. Placebo effects in osteoarthritis: implications for treatment and drug development. Nat. Rev. Rheumatol. 19, 613\u2013626 (2023).","journal-title":"Nat. Rev. Rheumatol."},{"key":"589_CR8","doi-asserted-by":"crossref","first-page":"e508","DOI":"10.1016\/S2665-9913(23)00163-7","volume":"5","author":"G. B. D. 2021 Osteoarthritis Collaborators","year":"2023","unstructured":"GBD 2021 Osteoarthritis Collaborators Global, regional, and national burden of osteoarthritis, 1990\u20132020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Rheumatol. 5, e508\u2013e522 (2023).","journal-title":"Lancet Rheumatol."},{"key":"589_CR9","doi-asserted-by":"crossref","first-page":"156333","DOI":"10.1016\/j.metabol.2025.156333","volume":"170","author":"B Zhang","year":"2025","unstructured":"Zhang, B., Chen, Y., Chen, Q. & Zhang, H. Exosomal miRNAs in muscle-bone crosstalk: mechanistic links, exercise modulation and implications for sarcopenia, osteoporosis and osteosarcopenia. Metabolism 170, 156333 (2025).","journal-title":"Metabolism"},{"key":"589_CR10","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/s41586-025-08771-z","volume":"641","author":"K Hatzikotoulas","year":"2025","unstructured":"Hatzikotoulas, K. et al. Translational genomics of osteoarthritis in 1 962 069 individuals. Nature 641, 1217\u20131224 (2025).","journal-title":"Nature"},{"key":"589_CR11","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/s41584-025-01305-x","volume":"21","author":"NR Fuggle","year":"2025","unstructured":"Fuggle, N. R. et al. Novel approaches to the stratified management of knee osteoarthritis. Nat. Rev. Rheumatol. 21, 684\u2013695 (2025).","journal-title":"Nat. Rev. Rheumatol."},{"key":"589_CR12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41392-023-01330-w","volume":"8","author":"Q Yao","year":"2023","unstructured":"Yao, Q. et al. Osteoarthritis: pathogenic signaling pathways and therapeutic targets. Signal Transduct. Target. Ther. 8, 56 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"589_CR13","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1126\/science.adx6649","volume":"391","author":"M Singla","year":"2026","unstructured":"Singla, M. et al. Inhibition of 15-hydroxy prostaglandin dehydrogenase promotes cartilage regeneration. Science 391, 1053\u20131062 (2026).","journal-title":"Science"},{"key":"589_CR14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41584-023-01052-x","volume":"20","author":"A Pandey","year":"2024","unstructured":"Pandey, A. & Bhutani, N. Profiling joint tissues at single-cell resolution: advances and insights. Nat. Rev. Rheumatol. 20, 7\u201320 (2024).","journal-title":"Nat. Rev. Rheumatol."},{"key":"589_CR15","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1016\/j.cmet.2022.09.025","volume":"34","author":"X Lv","year":"2022","unstructured":"Lv, X., Gao, F. & Cao, X. Skeletal interoception in bone homeostasis and pain. Cell Metab. 34, 1914\u20131931 (2022).","journal-title":"Cell Metab."},{"key":"589_CR16","volume":"12","author":"Z Wang","year":"2025","unstructured":"Wang, Z. et al. Hypothalamus regulates anabolic metabolism of articular cartilage superficial chondrocytes through PGE2 skeletal interoception. Adv. Sci. (Weinh.) 12, e2501039 (2025).","journal-title":"Adv. Sci. (Weinh.)"},{"key":"589_CR17","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41413-024-00316-w","volume":"12","author":"F Gao","year":"2024","unstructured":"Gao, F. et al. Brain regulates weight-bearing bone through PGE2 skeletal interoception: implication of ankle osteoarthritis and pain. Bone Res. 12, 16 (2024).","journal-title":"Bone Res."},{"key":"589_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-08097-7","volume":"10","author":"H Chen","year":"2019","unstructured":"Chen, H. et al. Prostaglandin E2 mediates sensory nerve regulation of bone homeostasis. Nat. Commun. 10, 181 (2019).","journal-title":"Nat. Commun."},{"key":"589_CR19","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41413-024-00328-6","volume":"12","author":"D Yang","year":"2024","unstructured":"Yang, D., Xu, J., Xu, K. & Xu, P. Skeletal interoception in osteoarthritis. Bone Res. 12, 22 (2024).","journal-title":"Bone Res."},{"key":"589_CR20","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jare.2024.03.022","volume":"69","author":"Z Guan","year":"2025","unstructured":"Guan, Z. et al. Sympathetic innervation induces exosomal miR-125 transfer from osteoarthritic chondrocytes, disrupting subchondral bone homeostasis and aggravating cartilage damage in aging mice. J. Adv. Res. 69, 245\u2013260 (2025).","journal-title":"J. Adv. Res."},{"key":"589_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36463-7","volume":"14","author":"W Huang","year":"2023","unstructured":"Huang, W. et al. Small molecule inhibitors of 15-PGDH exploit a physiologic induced-fit closing system. Nat. Commun. 14, 784 (2023).","journal-title":"Nat. Commun."},{"key":"589_CR22","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1182\/blood.2025029806","volume":"147","author":"E M\u00fcller","year":"2026","unstructured":"M\u00fcller, E., Kruse, B. & B\u00f6ttcher, J. P. Prostaglandins in cancer revisited: principles of production, mechanisms of immune regulation, and therapeutic perspectives. Blood 147, 713\u2013724 (2026).","journal-title":"Blood"},{"key":"589_CR23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41413-022-00201-4","volume":"10","author":"W Jiang","year":"2022","unstructured":"Jiang, W. et al. PGE2 activates EP4 in subchondral bone osteoclasts to regulate osteoarthritis. Bone Res. 10, 27 (2022).","journal-title":"Bone Res."},{"key":"589_CR24","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41584-025-01257-2","volume":"21","author":"AM Malfait","year":"2025","unstructured":"Malfait, A. M. & Obeidat, A. M. Targeting osteoarthritis where it hurts: the osteochondral junction. Nat. Rev. Rheumatol. 21, 319\u2013320 (2025).","journal-title":"Nat. Rev. Rheumatol."},{"key":"589_CR25","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/CIRCRESAHA.122.321475","volume":"132","author":"M Rubino","year":"2023","unstructured":"Rubino, M. et al. Inhibition of eicosanoid degradation mitigates fibrosis of the heart. Circ. Res. 132, 10\u201329 (2023).","journal-title":"Circ. Res."},{"key":"589_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-63615-8","volume":"16","author":"Z Xia","year":"2025","unstructured":"Xia, Z. et al. Structure and transport mechanism of the human prostaglandin transporter SLCO2A1. Nat. Commun. 16, 8124 (2025).","journal-title":"Nat. Commun."},{"key":"589_CR27","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41572-025-00594-6","volume":"11","author":"S Tang","year":"2025","unstructured":"Tang, S. et al. Osteoarthritis. Nat. Rev. Dis. Prim. 11, 10 (2025).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"589_CR28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00401-025-02878-3","volume":"149","author":"CE Hansen","year":"2025","unstructured":"Hansen, C. E. et al. Spatial mapping of the AA\u2013PGE2\u2013EP axis in multiple sclerosis lesions. Acta Neuropathol. 149, 39 (2025).","journal-title":"Acta Neuropathol."},{"key":"589_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-44689-2","volume":"15","author":"M Villa","year":"2024","unstructured":"Villa, M. et al. Prostaglandin E2 controls the metabolic adaptation of T cells to the intestinal microenvironment. Nat. Commun. 15, 451 (2024).","journal-title":"Nat. Commun."},{"key":"589_CR30","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41413-023-00304-6","volume":"12","author":"X Fan","year":"2024","unstructured":"Fan, X. et al. Spatial analysis of the osteoarthritis microenvironment: techniques, insights, and applications. Bone Res. 12, 7 (2024).","journal-title":"Bone Res."},{"key":"589_CR31","volume":"16","author":"S Tang","year":"2024","unstructured":"Tang, S. et al. Single-cell atlas of human infrapatellar fat pad and synovium implicates APOE signaling in osteoarthritis pathology. Sci. Transl. Med. 16, eadf4590 (2024).","journal-title":"Sci. Transl. Med."},{"key":"589_CR32","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1038\/s42003-025-08586-8","volume":"8","author":"RD Raut","year":"2025","unstructured":"Raut, R. D. et al. A multi-tissue human knee single-cell atlas identifies that osteoarthritis reduces regenerative tissue stem cells while increasing inflammatory pain macrophages. Commun. Biol. 8, 1146 (2025).","journal-title":"Commun. Biol."},{"key":"589_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43506-6","volume":"14","author":"S Gahbauer","year":"2023","unstructured":"Gahbauer, S. et al. Docking for EP4R antagonists active against inflammatory pain. Nat. Commun. 14, 8067 (2023).","journal-title":"Nat. Commun."},{"key":"589_CR34","volume":"122","author":"J Zhang","year":"2025","unstructured":"Zhang, J. et al. Osteocyte connexin hemichannels and prostaglandin E2 release dictate bone marrow mesenchymal stromal cell commitment. Proc. Natl. Acad. Sci. USA 122, e2412144122 (2025).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"589_CR35","doi-asserted-by":"crossref","first-page":"109904","DOI":"10.1016\/j.clim.2024.109904","volume":"260","author":"D Yang","year":"2024","unstructured":"Yang, D., Xu, K., Xu, X. & Xu, P. Revisiting prostaglandin E2: a promising therapeutic target for osteoarthritis. Clin. Immunol. 260, 109904 (2024).","journal-title":"Clin. Immunol."},{"key":"589_CR36","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.joca.2024.07.010","volume":"32","author":"T Neogi","year":"2024","unstructured":"Neogi, T., Dell\u2019Isola, A., Englund, M. & Turkiewicz, A. Frequent use of prescription NSAIDs among people with knee or hip osteoarthritis despite contraindications to or precautions with NSAIDs. Osteoarthr. Cartil. 32, 1628\u20131635 (2024).","journal-title":"Osteoarthr. Cartil."},{"key":"589_CR37","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1007\/s00228-022-03355-6","volume":"78","author":"E Hasvik","year":"2022","unstructured":"Hasvik, E., Gran, J. M., Haugen, A. J. & Gr\u00f8vle, L. Strategies to manage auxiliary pain medications in chronic pain trials: a topical review. Eur. J. Clin. Pharmacol. 78, 1377\u20131384 (2022).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"589_CR38","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/acr.25526","volume":"77","author":"JM Borst","year":"2025","unstructured":"Borst, J. M. et al. Placebo effect sizes in clinical trials of knee osteoarthritis using intra-articular injections of biologic agents. Arthritis Care Res. (Hoboken) 77, 998\u20131006 (2025).","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"589_CR39","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jpain.2022.08.010","volume":"24","author":"RR Edwards","year":"2023","unstructured":"Edwards, R. R. et al. Optimizing and accelerating the development of precision pain treatments for chronic pain: IMMPACT review and recommendations. J. Pain. 24, 204\u2013225 (2023).","journal-title":"J. Pain."},{"key":"589_CR40","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw9993","volume":"11","author":"C Robertson-Plouch","year":"2019","unstructured":"Robertson-Plouch, C. et al. A randomized clinical efficacy study targeting mPGES1 or EP4 in dogs with spontaneous osteoarthritis. Sci. Transl. Med. 11, eaaw9993 (2019).","journal-title":"Sci. Transl. Med."},{"key":"589_CR41","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41421-022-00382-6","volume":"8","author":"Y Jin","year":"2022","unstructured":"Jin, Y. et al. A novel prostaglandin E receptor 4 (EP4) small molecule antagonist induces articular cartilage regeneration. Cell Discov. 8, 24 (2022).","journal-title":"Cell Discov."},{"key":"589_CR42","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/jvim.13948","volume":"30","author":"L Rausch-Derra","year":"2016","unstructured":"Rausch-Derra, L., Huebner, M., Wofford, J. & Rhodes, L. A prospective, randomized, masked, placebo-controlled multisite clinical study of grapiprant, an EP4 prostaglandin receptor antagonist (PRA), in dogs with osteoarthritis. J. Vet. Intern. Med. 30, 756\u2013763 (2016).","journal-title":"J. Vet. Intern. Med."},{"key":"589_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-56861-6","volume":"9","author":"Y Murahashi","year":"2019","unstructured":"Murahashi, Y. et al. Oral administration of EP4-selective agonist KAG-308 suppresses mouse knee osteoarthritis development through reduction of chondrocyte hypertrophy and TNF secretion. Sci. Rep. 9, 20329 (2019).","journal-title":"Sci. Rep."},{"key":"589_CR44","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41586-024-07254-x","volume":"629","author":"SB Lacher","year":"2024","unstructured":"Lacher, S. B. et al. PGE2 limits effector expansion of tumour-infiltrating stem-like CD8+ T cells. Nature 629, 417\u2013425 (2024).","journal-title":"Nature"},{"key":"589_CR45","doi-asserted-by":"publisher","first-page":"7242","DOI":"10.1038\/s44318-025-00611-0","volume":"44","author":"Y Wu","year":"2025","unstructured":"Wu, Y. et al. Structural insights into selective and dual antagonism of EP2 and EP4 prostaglandin receptors. EMBO J. 44, 7242\u20137262 (2025).","journal-title":"EMBO J."},{"key":"589_CR46","doi-asserted-by":"crossref","first-page":"e70762","DOI":"10.1096\/fj.202500694RR","volume":"39","author":"JD Baas","year":"2025","unstructured":"Baas, J. D., Varga, J., Feghali-Bostwick, C., Peters-Golden, M. & Fortier, S. M. Distinct cAMP regulation in scleroderma lung and skin myofibroblasts governs their dedifferentiation via p38\u03b1 inhibition. FASEB J. 39, e70762 (2025).","journal-title":"FASEB J."},{"key":"589_CR47","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41413-023-00248-x","volume":"11","author":"N Wang","year":"2023","unstructured":"Wang, N. et al. Mechanotransduction pathways in articular chondrocytes and the emerging role of estrogen receptor-\u03b1. Bone Res. 11, 13 (2023).","journal-title":"Bone Res."},{"key":"589_CR48","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1136\/ard.2009.118620","volume":"70","author":"T Sato","year":"2011","unstructured":"Sato, T. et al. Prostaglandin EP2 receptor signalling inhibits the expression of matrix metalloproteinase 13 in human osteoarthritic chondrocytes. Ann. Rheum. Dis. 70, 221\u2013226 (2011).","journal-title":"Ann. Rheum. Dis."},{"key":"589_CR49","doi-asserted-by":"crossref","first-page":"151412","DOI":"10.1016\/j.ejcb.2024.151412","volume":"103","author":"S Schmidt","year":"2024","unstructured":"Schmidt, S., Klampfleuthner, F. A. M., Renkawitz, T. & Diederichs, S. Cause and chondroprotective effects of prostaglandin E2 secretion during mesenchymal stromal cell chondrogenesis. Eur. J. Cell Biol. 103, 151412 (2024).","journal-title":"Eur. J. Cell Biol."},{"key":"589_CR50","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1146\/annurev-pharmtox-040623-115054","volume":"64","author":"MJ Lohse","year":"2024","unstructured":"Lohse, M. J., Bock, A. & Zaccolo, M. G protein-coupled receptor signaling: new insights define cellular nanodomains. Annu. Rev. Pharmacol. Toxicol. 64, 387\u2013415 (2024).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"589_CR51","volume":"16","author":"Z Bai","year":"2024","unstructured":"Bai, Z. et al. Synovial fibroblast gene expression is associated with sensory nerve growth and pain in rheumatoid arthritis. Sci. Transl. Med. 16, eadk3506 (2024).","journal-title":"Sci. Transl. Med."},{"key":"589_CR52","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.104367","volume":"14","author":"UK Sokhi","year":"2025","unstructured":"Sokhi, U. K. et al. Opposing regulation of TNF responses by IFN-\u03b3 and a PGE2\u2013cAMP axis that is apparent in rheumatoid and immune checkpoint inhibitor-induced arthritis human IL-1\u03b2+ macrophages. eLife 14, RP104367 (2025).","journal-title":"eLife"},{"key":"589_CR53","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41413-025-00467-4","volume":"13","author":"P Lou","year":"2025","unstructured":"Lou, P. et al. Single-cell sequencing reveals a senescent immune landscape in bone marrow lesions inducing articular cartilage damage in osteoarthritis. Bone Res. 13, 94 (2025).","journal-title":"Bone Res."},{"key":"589_CR54","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.joca.2025.04.001","volume":"33","author":"TL Boyer","year":"2025","unstructured":"Boyer, T. L. et al. Cartilage targeting cationic peptide carriers display deep cartilage penetration and retention in a rabbit model of post-traumatic osteoarthritis. Osteoarthr. Cartil. 33, 721\u2013734 (2025).","journal-title":"Osteoarthr. Cartil."},{"key":"589_CR55","volume":"16","author":"R Deng","year":"2024","unstructured":"Deng, R. et al. Chondrocyte membrane-coated nanoparticles promote drug retention and halt cartilage damage in rat and canine osteoarthritis. Sci. Transl. Med. 16, eadh9751 (2024).","journal-title":"Sci. Transl. Med."},{"key":"589_CR56","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1038\/s41551-023-01025-1","volume":"7","author":"E Bracho-Sanchez","year":"2023","unstructured":"Bracho-Sanchez, E. et al. Suppression of local inflammation via galectin-anchored indoleamine 2,3-dioxygenase. Nat. Biomed. Eng. 7, 1156\u20131169 (2023).","journal-title":"Nat. Biomed. Eng."},{"key":"589_CR57","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1136\/ard-2023-224420","volume":"83","author":"Y Fan","year":"2024","unstructured":"Fan, Y. et al. Unveiling inflammatory and prehypertrophic cell populations as key contributors to knee cartilage degeneration in osteoarthritis using multi-omics data integration. Ann. Rheum. Dis. 83, 926\u2013944 (2024).","journal-title":"Ann. Rheum. Dis."},{"key":"589_CR58","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41584-025-01275-0","volume":"21","author":"C Matta","year":"2025","unstructured":"Matta, C. et al. Insights into chondrocyte populations in cartilaginous tissues at the single-cell level. Nat. Rev. Rheumatol. 21, 465\u2013477 (2025).","journal-title":"Nat. Rev. Rheumatol."},{"key":"589_CR59","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jbmr\/zjad009","volume":"39","author":"J Li","year":"2024","unstructured":"Li, J. et al. Synovium and infrapatellar fat pad share common mesenchymal progenitors and undergo coordinated changes in osteoarthritis. J. Bone Miner. Res. 39, 161\u2013176 (2024).","journal-title":"J. Bone Miner. Res."},{"key":"589_CR60","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.joca.2025.12.013","volume":"34","author":"F Scerif","year":"2026","unstructured":"Scerif, F. & Eldridge, S. E. Osteoarthritis year in review 2025: biology. Osteoarthr. Cartil. 34, 213\u2013220 (2026).","journal-title":"Osteoarthr. Cartil."},{"key":"589_CR61","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.joca.2023.07.012","volume":"32","author":"RF Bergman","year":"2024","unstructured":"Bergman, R. F. et al. Sexual dimorphism of the synovial transcriptome underpins greater PTOA disease severity in male mice following joint injury. Osteoarthr. Cartil. 32, 1060\u20131073 (2024).","journal-title":"Osteoarthr. Cartil."},{"key":"589_CR62","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1002\/art.42530","volume":"75","author":"T Geraghty","year":"2023","unstructured":"Geraghty, T. et al. Age-associated changes in knee osteoarthritis, pain-related behaviors, and dorsal root ganglia immunophenotyping of male and female mice. Arthritis Rheumatol. 75, 1770\u20131780 (2023).","journal-title":"Arthritis Rheumatol."},{"key":"589_CR63","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ade4645","volume":"9","author":"J Bolander","year":"2023","unstructured":"Bolander, J. et al. The synovial environment steers cartilage deterioration and regeneration. Sci. Adv. 9, eade4645 (2023).","journal-title":"Sci. Adv."},{"key":"589_CR64","volume":"12","author":"C Palma","year":"2025","unstructured":"Palma, C. et al. A compartmentalized joint-on-chip (JoC) model to unravel the contribution of cartilage and synovium to osteoarthritis pathogenesis. Adv. Sci. (Weinh.) 12, e00374 (2025).","journal-title":"Adv. Sci. (Weinh.)"},{"key":"589_CR65","first-page":"1054","volume":"32","author":"M Dvir-Ginzberg","year":"2024","unstructured":"Dvir-Ginzberg, M., Maatuf, Y. H. & Mobasheri, A. Do we understand sex-related differences governing dimorphic disease mechanisms in preclinical animal models of osteoarthritis? Osteoarthr. Cartil 32, 1054\u20131057 (2024).","journal-title":"Cartil"},{"key":"589_CR66","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41586-023-06888-7","volume":"625","author":"W Fu","year":"2024","unstructured":"Fu, W. et al. NaV1.7 as a chondrocyte regulator and therapeutic target for osteoarthritis. Nature 625, 557\u2013565 (2024).","journal-title":"Nature"},{"key":"589_CR67","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.joca.2023.06.006","volume":"31","author":"MA Karsdal","year":"2023","unstructured":"Karsdal, M. A. et al. Reflections from the OARSI 2022 clinical trials symposium: the pain of OA\u2014deconstruction of pain and patient-reported outcome measures for the benefit of patients and clinical trial design. Osteoarthr. Cartil. 31, 1293\u20131302 (2023).","journal-title":"Osteoarthr. Cartil."},{"key":"589_CR68","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13075-025-03561-4","volume":"27","author":"E Reihs","year":"2025","unstructured":"Reihs, E. et al. Beyond symptomatic alignment: evaluating the integration of causal mechanisms in matching animal models with human pathotypes in osteoarthritis research. Arthritis Res. Ther. 27, 109 (2025).","journal-title":"Arthritis Res. Ther."},{"key":"589_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47633-6","volume":"15","author":"L Zhao","year":"2024","unstructured":"Zhao, L., Lai, Y., Jiao, H. & Huang, J. Nerve growth factor receptor limits inflammation to promote remodeling and repair of osteoarthritic joints. Nat. Commun. 15, 3225 (2024).","journal-title":"Nat. Commun."},{"key":"589_CR70","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1056\/NEJMoa2403664","volume":"391","author":"H Bliddal","year":"2024","unstructured":"Bliddal, H. et al. Once-weekly semaglutide in persons with obesity and knee osteoarthritis. N. Engl. J. Med. 391, 1573\u20131583 (2024).","journal-title":"N. Engl. J. Med."},{"key":"589_CR71","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1093\/rheumatology\/keae610","volume":"64","author":"J Tambiah","year":"2025","unstructured":"Tambiah, J., Kennedy, S., Swearingen, C., McAlindon, T. & Yazici, Y. Impact of structural severity on outcomes in knee osteoarthritis: an analysis of data from phase 2 and phase 3 lorecivivint clinical trials. Rheumatol. (Oxf.) 64, 2583\u20132590 (2025).","journal-title":"Rheumatol. (Oxf.)"},{"key":"589_CR72","first-page":"847","volume":"43","author":"Y Yazici","year":"2025","unstructured":"Yazici, Y. et al. A phase 3, 28-week, multicentre, randomised, double-blind, placebo-controlled trial (OA-10) to evaluate the efficacy and safety of a single injection of lorecivivint in the target knee joint of moderately to severely symptomatic osteoarthritis patients. Clin. Exp. Rheumatol. 43, 847\u2013853 (2025).","journal-title":"Clin. Exp. Rheumatol."},{"key":"589_CR73","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1530\/EOR-2025-0022","volume":"10","author":"D Previtali","year":"2025","unstructured":"Previtali, D., Boffa, A., Di Laura Frattura, G., Merli, G. & Filardo, G. Placebo response to intra-articular injections in knee osteoarthritis: magnitude, evolution over time, and influencing factors. A systematic review and meta-analysis with meta-regression. EFORT Open Rev. 10, 782\u2013795 (2025).","journal-title":"EFORT Open Rev."},{"key":"589_CR74","volume":"9","author":"K Zhou","year":"2023","unstructured":"Zhou, K. et al. A \u201cbest-in-class\u201d systemic biomarker predictor of clinically relevant knee osteoarthritis structural and pain progression. Sci. Adv. 9, eabq5095 (2023).","journal-title":"Sci. Adv."},{"key":"589_CR75","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41584-023-00971-z","volume":"19","author":"RT Hansen","year":"2023","unstructured":"Hansen, R. T., Chenu, C., Sofat, N. & Pitsillides, A. A. Bone marrow lesions: plugging the holes in our knowledge using animal models. Nat. Rev. Rheumatol. 19, 429\u2013445 (2023).","journal-title":"Nat. Rev. Rheumatol."},{"key":"589_CR76","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.joca.2024.01.005","volume":"32","author":"TL Vincent","year":"2024","unstructured":"Vincent, T. L. & Miller, R. E. Molecular pathogenesis of OA pain: past, present, and future. Osteoarthr. Cartil. 32, 398\u2013405 (2024).","journal-title":"Osteoarthr. Cartil."},{"key":"589_CR77","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/s41584-024-01118-4","volume":"20","author":"RC Nordberg","year":"2024","unstructured":"Nordberg, R. C. et al. Recent advancements in cartilage tissue engineering innovation and translation. Nat. Rev. Rheumatol. 20, 323\u2013346 (2024).","journal-title":"Nat. Rev. Rheumatol."},{"key":"589_CR78","doi-asserted-by":"crossref","first-page":"6649","DOI":"10.1021\/acsnano.2c12376","volume":"17","author":"C Zhang","year":"2023","unstructured":"Zhang, C., Vedadghavami, A., He, T., Charles, J. F. & Bajpayee, A. G. Cationic carrier mediated delivery of anionic contrast agents in low doses enable enhanced computed tomography imaging of cartilage for early osteoarthritis diagnosis. ACS Nano 17, 6649\u20136663 (2023).","journal-title":"ACS Nano"},{"key":"589_CR79","doi-asserted-by":"crossref","first-page":"152070","DOI":"10.1016\/j.semarthrit.2022.152070","volume":"56","author":"JS Kim","year":"2022","unstructured":"Kim, J. S. et al. FDA\/Arthritis Foundation osteoarthritis drug development workshop recap: assessment of long-term benefit. Semin. Arthritis Rheum. 56, 152070 (2022).","journal-title":"Semin. Arthritis Rheum."},{"key":"589_CR80","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adg1485","volume":"15","author":"MA Bakooshli","year":"2023","unstructured":"Bakooshli, M. A. et al. Regeneration of neuromuscular synapses after acute and chronic denervation by inhibiting the gerozyme 15-prostaglandin dehydrogenase. Sci. Transl. Med. 15, eadg1485 (2023).","journal-title":"Sci. Transl. Med."},{"key":"589_CR81","volume":"122","author":"Y Koh","year":"2025","unstructured":"Koh, Y. et al. Inhibiting 15-PGDH blocks blood-brain barrier deterioration and protects mice from Alzheimer\u2019s disease and traumatic brain injury. Proc. Natl. Acad. Sci. USA 122, e2417224122 (2025).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"589_CR82","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0140-6736(23)01572-6","volume":"402","author":"Y Wang","year":"2023","unstructured":"Wang, Y. et al. Methotrexate to treat hand osteoarthritis with synovitis (METHODS): an Australian, multisite, parallel-group, double-blind, randomised, placebo-controlled trial. Lancet 402, 1764\u20131772 (2023).","journal-title":"Lancet"},{"key":"589_CR83","first-page":"101169","volume":"50","author":"T Jiang","year":"2024","unstructured":"Jiang, T. et al. Bidirectional association identified between synovitis and knee and hand osteoarthritis: a general population-based study. Lancet Reg. Health West. Pac. 50, 101169 (2024).","journal-title":"Lancet Reg. Health West. Pac."},{"key":"589_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36468-2","volume":"14","author":"S Zhang","year":"2023","unstructured":"Zhang, S. et al. Remodeling articular immune homeostasis with an efferocytosis-informed nanoimitator mitigates rheumatoid arthritis in mice. Nat. Commun. 14, 817 (2023).","journal-title":"Nat. Commun."},{"key":"589_CR85","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1038\/s41590-024-02011-8","volume":"25","author":"T Hasegawa","year":"2024","unstructured":"Hasegawa, T. et al. Macrophages and nociceptor neurons form a sentinel unit around fenestrated capillaries to defend the synovium from circulating immune challenge. Nat. Immunol. 25, 2270\u20132283 (2024).","journal-title":"Nat. Immunol."},{"key":"589_CR86","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-63782-8","volume":"16","author":"R Nassini","year":"2025","unstructured":"Nassini, R. et al. Targeting prostaglandin E2 receptor 2 in Schwann cells inhibits inflammatory pain but not inflammation. Nat. Commun. 16, 8262 (2025).","journal-title":"Nat. Commun."},{"key":"589_CR87","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s13075-024-03409-3","volume":"26","author":"JM Schulz","year":"2024","unstructured":"Schulz, J. M. et al. Changes and associations between synovial fluid and magnetic resonance imaging markers of osteoarthritis after high tibial osteotomy. Arthritis Res. Ther. 26, 176 (2024).","journal-title":"Arthritis Res. Ther."},{"key":"589_CR88","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1302\/2046-3758.117.BJR-2021-0355.R1","volume":"11","author":"Q Sun","year":"2022","unstructured":"Sun, Q. et al. Peripheral nerves in the tibial subchondral bone: the role of pain and homeostasis in osteoarthritis. Bone Jt. Res. 11, 439\u2013452 (2022).","journal-title":"Bone Jt. Res."},{"key":"589_CR89","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41413-019-0071-x","volume":"7","author":"M Tu","year":"2019","unstructured":"Tu, M. et al. Inhibition of cyclooxygenase-2 activity in subchondral bone modifies a subtype of osteoarthritis. Bone Res. 7, 29 (2019).","journal-title":"Bone Res."},{"key":"589_CR90","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.1016\/j.cell.2024.07.033","volume":"187","author":"H Kantarci","year":"2024","unstructured":"Kantarci, H. et al. Schwann cell-secreted PGE2 promotes sensory neuron excitability during development. Cell 187, 4690\u20134712.e30 (2024).","journal-title":"Cell"},{"key":"589_CR91","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2409729122","volume":"122","author":"N Joshi","year":"2025","unstructured":"Joshi, N. et al. A mechanically resilient soft hydrogel improves drug delivery for treating post-traumatic osteoarthritis in physically active joints. Proc. Natl. Acad. Sci. USA 122, e2409729122 (2025).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"589_CR92","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56727-8","volume":"16","author":"W Qin","year":"2025","unstructured":"Qin, W. et al. Neurovascularization inhibiting dual responsive hydrogel for alleviating the progression of osteoarthritis. Nat. Commun. 16, 1390 (2025).","journal-title":"Nat. Commun."},{"key":"589_CR93","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.joca.2023.11.015","volume":"32","author":"LE Diamond","year":"2024","unstructured":"Diamond, L. E., Grant, T. & Uhlrich, S. D. Osteoarthritis year in review 2023: biomechanics. Osteoarthr. Cartil. 32, 138\u2013147 (2024).","journal-title":"Osteoarthr. Cartil."},{"key":"589_CR94","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/s41584-024-01102-y","volume":"20","author":"VB Kraus","year":"2024","unstructured":"Kraus, V. B. & Hsueh, M. F. Molecular biomarker approaches to prevention of post-traumatic osteoarthritis. Nat. Rev. Rheumatol. 20, 272\u2013289 (2024).","journal-title":"Nat. Rev. Rheumatol."}],"container-title":["Bone Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41413-026-00589-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41413-026-00589-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41413-026-00589-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:46:50Z","timestamp":1792086410000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41413-026-00589-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,15]]},"references-count":94,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["589"],"URL":"https:\/\/doi.org\/10.1038\/s41413-026-00589-3","relation":{},"ISSN":["2095-6231"],"issn-type":[{"value":"2095-6231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,15]]},"assertion":[{"value":"31 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This review article does not involve human or animal subjects. Therefore, ethical approval was not required for this study.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"105"}}